Tanke Biosciences Corporation, a leading innovator in the biotechnology sector, is headquartered in the United States. Founded in 2015, the company has rapidly established itself as a key player in the development of advanced biopharmaceuticals and cutting-edge diagnostic solutions. With a focus on harnessing the power of synthetic biology, Tanke Biosciences offers unique products that address critical health challenges. The company operates primarily in North America and has expanded its reach into Europe and Asia, showcasing its commitment to global health advancements. Tanke's core offerings include proprietary gene editing technologies and tailored therapeutic solutions, which distinguish it from competitors in the market. Recognised for its scientific excellence, Tanke Biosciences continues to push the boundaries of innovation, contributing significantly to the future of healthcare.
How does Tanke Biosciences Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Tanke Biosciences Corporation's score of 31 is higher than 57% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Tanke Biosciences Corporation, headquartered in the US, has set ambitious climate commitments aimed at reducing its carbon footprint. Although specific emissions data is currently unavailable, the company has established significant reduction targets. Tanke aims to reduce absolute Scope 1 and Scope 2 emissions by 50% by FY2030, using FY2018 as the baseline year. This commitment reflects a proactive approach to mitigating climate impact. Additionally, Tanke has pledged to achieve net-zero greenhouse gas emissions across its entire value chain by FY2050, again referencing FY2018 as the starting point. These targets demonstrate Tanke's dedication to sustainability and align with industry standards for climate action. The company is focused on both near-term and long-term strategies to address its environmental responsibilities.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Tanke Biosciences Corporation has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
